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IntroductIon
Appropriate statistical analysis is critical for 
interpreting results from published literature to ad-
dress a specific clinical or management question. 
Descriptive statistics are used to summarize study 
data; however, describing the data collected from 
a group of experimental or observational units in a 
study does not allow one to make conclusions be-
yond the study population. Inferential statistics pro-
vide a mechanism to use the study data to evaluate 
hypotheses and aid decision-making applied to a 
larger, unmeasured population.
In most studies, the outcome of interest differs 
numerically between treatment or observation groups, 
but the reader is most likely interested in determining 
if the observed numerical difference is an accurate de-
scription of the wider population or if the findings oc-
curred by chance. Researchers recognize that one sam-
pling of a few representative animals in a population is 
not expected to be the same as another sampling of the 
same population and that neither sampling is a perfect 
depiction of the entire population; hence, a numerical 
difference between treatment groups or observation 
groups has some probability of being due to chance. 
Inferential statistics uses estimates of the outcome of 
interest, estimates of precision (e.g., SE or confidence 
interval [cI]), and test statistics to aid the interpreta-
tion of study data in relation to the study hypotheses. 
Reading the scientific literature does not require an 
intricate understanding of how to perform appropriate 
statistics for every potential study design; however, a 
basic knowledge of how to assess the internal valid-
ity of studies and interpret statistical results is impor-
tant for making inferences from published research 
to guide decision-making in animal and veterinary 
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ABStrAct: Appropriate statistical analysis is criti-
cal in interpreting results from published literature to 
answer clinical and management questions. Internal 
validity is an assessment of whether the study design 
and statistical analysis are appropriate for the hypoth-
eses and study variables while controlling for bias and 
confounding. External validity is an assessment of the 
appropriateness of extrapolation of the study results 
to other populations. Knowledge about whether 
treatment or observation groups are truly different is 
unknown, but studies can be broadly categorized as 
exploratory or discovery, based on knowledge about 
previous research, biology, and study design, and this 
categorization affects interpretation. Confidence inter-
vals, P-values, prediction intervals, credible intervals, 
and other decision aids are used singly or in combina-
tion to provide evidence for the likelihood of a given 
model but can be interpreted only if the study is inter-
nally valid. These decision aids do not test for bias, 
study design, or the appropriateness of applying study 
results to other populations dissimilar to the popula-
tion tested. The biologic and economic importance of 
the magnitude of difference between treatment groups 
or observation groups as estimated by the study data 
and statistical interpretation is important to consider in 
clinical and management decisions. Statistical results 
should be interpreted in light of the specific question 
and production system addressed, the study design, 
and knowledge about pertinent aspects of biology to 
appropriately aid decisions.
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sciences. The objective of this article is to describe the 
role of statistics in interpreting research and how to use 
statistical evidence to make inferences when answering 
clinical and management questions.
tYPES oF VArIABlES
Understanding the type and distribution of each 
study variable is important to determine the most ap-
propriate statistical test. Variables fall into 2 main 
types, quantitative or qualitative, with multiple dis-
tinctions within those categories. Readers should in-
vestigate the type of variables being evaluated to as-
sess if appropriate analyses were performed.
Quantitative continuous measurements can take on 
any numerical value. For example, BW is a continuous 
variable because animal weight can be reported in any in-
crement allowed by the precision of the scale used (1 kg, 
1 g, 1 mg, etc.). Quantitative discrete measurements such 
as litter size or counts of events must be whole numbers. 
Quantitative measurements can be made objectively (vs. 
subjectively) and the difference between each quantita-
tive measurement increment is exactly the same (e.g., the 
weight difference between 1 and 2 kg is exactly the same 
as the difference in weight between 21 and 22 kg).
In contrast, descriptions are used for qualitative 
variables (dead vs. alive, sick vs. healthy, male vs. fe-
male, BCS, etc.). Sometimes scoring systems such as 
clinical illness score (cIS), lameness score, or BCS 
are reported as numerals, but, in fact, they are qualita-
tive, not quantitative. Clinical illness scoring systems of 
feedlot cattle commonly include a score ranging from 0 
to 4 with a score of 0 indicating apparently healthy ani-
mals and a score of 4 representing severely ill animals 
(Perino and Apley, 1998). These qualitative outcomes 
are not continuous or discrete numbers because each 
qualitative descriptive interval is not the same (e.g., the 
difference in disease severity between animals with CIS 
of 1 vs. 2 is not the same as the difference in disease 
severity between animals with CIS of 3 vs. 4). Scoring 
systems are commonly ordinal (ordered), as there is a 
relationship of severity or amount as the scale increases 
or decreases, but these scoring systems are still qualita-
tive because they are being used to provide descriptions, 
not measurements. A method to determine whether 
scoring systems are qualitative or quantitative in nature 
is to determine if the scale could have been assigned 
letters instead of numbers and still have the same inter-
pretation. If letters could be assigned to the scale, then 
the scoring system is qualitative.
Although reliability and agreement is important for 
all data collection methods, when the data is subjective, 
it is particularly important that the scoring system be 
validated to provide the reader an estimate of both the 
intra- and inter-rater agreement and reliability (Kottner 
et al., 2011). In addition, if ordinal data is collected and 
then levels within the scoring system are merged to cre-
ate binary classifications for analysis, the justification 
for which levels are merged should be clearly stated and 
based on demonstrated improvements in reliability or 
agreement (Schlageter-Tello et al., 2014). Without a clear 
description and validation of the data collection method, 
the reader cannot interpret reported associations.
It is important to recognize that different statisti-
cal tests are used with qualitative and quantitative data. 
As an example, a research study could be conducted 
to compare the impact of treating cattle for bovine re-
spiratory disease with 2 different antimicrobials (treat-
ments A and B), and the outcomes of interest are ADG, 
mortality risk, and CIS. These outcomes represent 
different variable types because ADG is a continuous 
variable, mortality is binary data that can be only “yes” 
or “no” for an individual animal, and CIS is a quali-
tative variable that can assume only a limited number 
of ordinal descriptions. Figure 1 provides examples 
of each distribution for ADG, mortality risk, and CIS. 
Statistical software cannot detect if an entered numeral 
is a qualitative description rather than a quantitative 
measurement; therefore, statistical packages will run 
inappropriate calculations and report inaccurate results 
if the researcher does not recognize this common mis-
take. The same statistical methods should not be used to 
evaluate both CIS and ADG even if both are recorded 
using numerals. Additionally, it is improper to calculate 
a mean for qualitative data, such as CIS (for example, 
reporting a mean CIS of 1.3 for treatment A and 2.7 for 
treatment B). The goal of presenting a summary statis-
tic is to represent the population as a whole. Reporting 
a qualitative variable such as CIS as having a mean of 
1.3 or 2.7 is nonsensical because these values would not 
represent any actual animals, as study subjects could 
not receive a score between mutually exclusive catego-
ries. Medians should be presented as a summary sta-
tistic of central tendency for data where nonparametric 
tests will be used for inference testing.
Studies of almost any size result in numerical dif-
ferences in the outcomes of interest. The function of 
inferential statistics is to quantify the likelihood that if 
the treatment or risk factor had no effect, a difference as 
great as or greater than that observed in the study would 
be due to chance and, by inference, some qualitative 
level of confidence that the difference observed was due 
to the treatment or risk factor of interest. Expanding on 
the preceding bovine respiratory disease treatment ex-
ample, the ADG for cattle receiving treatment A could 
have been 1.5 kg/(animal∙d), with a morbidity (abnor-
mal CIS) risk of 21%, and a mortality risk of 0.6%; cat-
tle receiving treatment B could have an ADG of 0.5 kg/
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(animal∙d), a morbidity risk of 39%, and a mortality 
risk of 1.5%. The raw data supports the hypothesis that 
treatment A offers health and performance advantages, 
but it is impossible to determine whether the observed 
difference in the raw data is most likely associated with 
chance or a treatment effect. Although we can safely 
conclude that cattle receiving treatment A did, in fact, 
have better growth and health performance than cattle 
receiving treatment B in the sample population, our 
actual clinical question is, “Will cattle receiving treat-
ment A have better growth and health performance than 
cattle receiving treatment B in future populations?” Or, 
stated another way, “Is the direction and magnitude of 
the numerical difference between treatment groups we 
observed in the experiment likely just due to chance?”
Traditional null hypothesis inference testing method-
ology will provide the probability (P-value) that if the 
model assumptions are true (including, most commonly, 
that the treatments were truly not different), differences 
as great as or greater than that observed in the study 
would occur by chance. Interpreting potential outcome 
variable differences is based on understanding the under-
lying variable characteristics. Weight gain in this study 
is monitored by a continuous variable with an expected 
normal (bell-shaped) distribution in the entire population 
(Fig. 1A). In other words, the expected distribution of an-
imals’ weight gain within the study population could be 
described by the mean ADG for the group as the center 
of the bell-shaped curve and the variation of individual 
animal ADG within the population as the width of the 
bell-shaped curve as described by the term standard devi-
ation. A normal distribution has outcomes from animals 
in the population distributed evenly on both sides of the 
mean with approximately 66, 95, and 99% of the popu-
lation being located within 1, 2, and 3 standard devia-
tions of the mean, respectively. Therefore, the statistical 
test must evaluate the likelihood that mean observations 
as extreme as 0.5 and 1.5 kg/(animal∙d) could be drawn 
from a single population. In contrast to ADG, mortality 
risk assumes a much different distribution and is often 
skewed to the right (Fig. 1B; Theurer et al., 2015). Using 
a scoring system such as CIS results in discrete, ordinal 
outcomes, which may also be skewed (Fig. 1C).
Data distributions of study variables can have very 
different appearances that influence which statistical 
tests can be applied. Many statistical tests assume that 
the study data have a normal (bell-shaped or Gaussian) or 
near-normal distribution. If data do not have normal dis-
tribution, either the data should be transformed to obtain 
a near-normal distribution or other statistical tests that are 
appropriate for skewed distributions must be used (Petrie 
and Watson, 2013). When statistical tests are not appro-
priately applied, results can be nonsensical or misleading.
A common error in animal research is to use incor-
rect statistical tests for categorical data such as CIS 
or lameness scores, which are not quantitative and do 
not have a normal distribution. Appropriate methods 
to evaluate skewed, qualitative data compare the prob-
ability of each treatment or observation group having 
the observed percentages of animals in each category, 
given the assumption that all groups were drawn from 
the same population (Davis et al., 2009). Once the 
Figure 1. Examples of common outcome variables with normal (ADG; A), binomial or skewed (mortality risk; B), and discrete (clinical illness scores; 
C) data distributions.
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appropriate tests are selected, the next step is to inter-
pret what the inferential statistics are communicating 
relative to a clinical or management question.
rElAtIonSHIP BEtWEEn IndEPEndEnt 
And dEPEndEnt VArIABlES
Because many studies in animal and veterinary sci-
ence involve questions about the relationship between 2 
or more variables, the statistical technique of regression 
analysis is frequently reported. Depending on the type 
of dependent variable and whether or not the model 
meets certain assumptions, different models (e.g., lin-
ear, logistic, Poisson, Cox, polynomial, ridge, etc.) are 
appropriate to analyze different study data (Dugard and 
Staines, 2010). Multiple linear regression is a commonly 
reported regression analysis, but this model makes sev-
eral important assumptions, and if those assumptions 
are not met, the results may not be reliable (Kaps and 
Lambertson, 2004). In particular, violations of linearity 
or additivity or of independence are extremely serious 
and indicate that the linear regression model is not ap-
propriate. Violations of homoscedasticity or normality 
of the error distribution can make the model results less 
trustworthy. Multiple variable prediction models for 
prognosis or diagnosis are particularly relevant to an-
swer clinical or management questions in animal and 
veterinary science, and a reporting guideline has been 
published to address important aspects of model devel-
opment and validation (Collins et al., 2015).
Internal and External Research Validity
Inferential statistics are not able to differentiate 
between bias and meaningful treatment differences, 
so experimental design features to control for bias and 
confounding must be assured before inferential sta-
tistics are used or interpreted. Internally valid studies 
collect data in a repeatable manner while controlling 
for bias and confounding through a research design to 
remove or control factors that could systematically in-
fluence study outcomes away from the truth. Studies 
with high internal validity will generate results influ-
enced only by the study factors of interest, whereas 
the outcomes of studies with poor internal validity 
could be altered away from the truth due to factors 
that are not accounted for in the study design.
Statistical tests do not evaluate whether or not data 
are biased; therefore, studies with low internal validity 
should not be used for decision-making regardless of the 
statistical results (White and Larson, 2015a,b). If incor-
rect experimental design or statistical methods are used, 
recognize that the study results can be nonsense at best 
and misleading at worst. Unfortunately, readers cannot 
assume reports in animal science and veterinary journals 
are always based on appropriately designed studies and 
correctly applied statistical tests (Shott, 2011).
A number of reporting guidelines have been de-
veloped with the primary purpose being to assist au-
thors to write accurate, complete, and clear reports 
of their research studies. In addition to their value to 
authors, these guidelines also aid readers critically ap-
praise and interpret scientific literature by focusing at-
tention on the aspects of materials and methods and 
study results that could indicate increased risk of bias 
in the study design, analysis, or reporting. The Equator 
(Enhancing the QUAlity and Transparency of health 
Research) network website (http://www.equator-net-
work.org; accessed 20 Oct. 2015) provides an up-to-
date source for reporting guidelines for many different 
study types (Simera and Altman, 2013).
External validity characterizes the appropriateness 
of applying the research results to populations other 
than the study population. For example, if a study was 
performed using a population of lightweight calves, the 
results should be extrapolated only to similar popula-
tions of lightweight calves if the biological system eval-
uated is likely to be different between weight groups.
Confirmatory versus Discovery Hypotheses
Research hypotheses can be placed into 2 broad 
categories: confirmatory and discovery. A confirmatory 
hypothesis tests a specific relationship that is proposed 
during the study design phase and is supported by pre-
vious investigations, whereas discovery hypotheses are 
suggested and tested based on the data generated by the 
study. Comparing the proportion of animals diagnosed 
with a particular disease with a positive clinical response 
when given a new therapy to the percentage of animals 
given a placebo control treatment that have a positive 
clinical response is an example of a confirmatory hy-
pothesis if previous research identified the new therapy 
as a potentially effective treatment. In contrast, an exam-
ple of a discovery hypothesis would be to investigate po-
tential associations between multiple laboratory indices 
and animal disease status without identifying a specific 
association of interest before initiating the study.
Using statistical tests to evaluate multiple discovery 
hypotheses suggested by the data must be done cautious-
ly to avoid mistaking chance statistical associations for 
biologically meaningful relationships. Many statistical 
tests report a P-value representing the probability that if 
the treatment or observation groups were truly not differ-
ent, a difference as great as or greater than the one identi-
fied between 2 study variables is due to chance. If there 
are no true differences between treatment or observation 
groups, the likelihood of incorrectly concluding that that 
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a difference exists will increase in proportion with the 
number of discovery hypotheses examined.
Consider a study collecting samples from multiple 
animals to evaluate the relationship between complete 
blood count components with the presence or absence 
of infectious respiratory disease. We could use a con-
firmatory hypothesis stated before the study begins and 
based on previous research that total white cell count is 
associated with the presence of pneumonia (Ellis et al., 
1998; Hanzlicek et al., 2010). If the inferential statistics 
support this relationship, our hypothesis is strengthened. 
Therefore, we feel more comfortable extrapolating clini-
cal conclusions based on this data to similar populations.
In a contrasting study design, if our study did not 
have a specific confirmatory hypothesis but, rather, 
started with discovery hypotheses that 1 or more com-
plete blood count components could be associated with 
animals having respiratory disease, our interpretation of 
the statistical results would be different compared with 
interpretation in the confirmatory study. If 20 indepen-
dent blood components were evaluated with a P-value 
of ≤0.05 designated for statistical significance, then it is 
likely that even if no true biologic relationship exists be-
tween any of the tested variables and pneumonia status, 
at least 1 association with the outcome of interest will 
likely have a P-value less than 0.05 due to chance. Our 
inferences using the same data and the same significance 
level should change, based on the type of hypothesis and 
evaluation methods. Methods exist (e.g., Bonferroni cor-
rection, Tukey adjustment, and decreasing significance 
level) that allow inferences based on studies exploring 
multiple hypotheses and making multiple comparisons 
within an individual statistical model and should be used 
and reported in these types of studies.
Interpreting statistics should always be done with 
a clear understanding of the research hypothesis. A 
well-designed and well-conducted study with a single 
confirmatory hypothesis can often be used to strongly 
influence decision-making, whereas a study with many 
discovery hypotheses is best interpreted as a project to 
identify potential future confirmatory studies.
IntErPrEtInG P-VAluES  
BEloW tHE SIGnIFIcAncE lEVEl  
(E.G., P ≤ 0.05 oR P ≤ 0.01, ETC.)
Statistical tests determine the probability that if 
there were truly no difference between treatment or ob-
servation groups, a difference in outcomes as great as or 
greater than the one observed in the study could have 
been due to chance. The probability is commonly ex-
pressed as a P-value. Although P-values less than 0.05 
have traditionally been considered “statistically signifi-
cant,” other significance (α) levels may be selected in 
different situations based on the type of research ques-
tion and the level of certainty desired (Anderson et al., 
1990). In response to criticisms and misunderstandings 
surrounding the interpretation of P-values, the American 
Statistical Association published a statement that, among 
other considerations, strongly stated that “Practices that 
reduce data analysis or scientific inference to mechanical 
‘bright-line’ rules (such as P < 0.05) for justifying sci-
entific claims or conclusions can lead to erroneous be-
liefs and poor decision-making. A conclusion does not 
immediately become ‘true’ on one side of the divide and 
‘false’ on the other.” And, “the widespread use of ‘statis-
tical significance’ (generally interpreted as P ≤ 0.05) as 
a license for making a claim of a scientific finding (or 
implied truth) leads to considerable distortion of the sci-
entific process” (Wasserstein and Lazar, 2016, p. 131).
Importantly, calculations of P-values do not 
take into consideration the risk for bias or confound-
ing, meaning that a biased study may very well have 
a very low P-value but not provide true information 
on the effect of the treatment or risk factor of interest. 
Therefore, P-values provide useful information only 
in well-designed and well-conducted research studies 
and can be misleading if interpreted from studies that 
are poorly designed to control for bias and confound-
ing. In addition, P-values do not provide information 
about the magnitude of difference or the importance of 
an effect because identical P-values calculated from 
studies with different sample size do not provide evi-
dence for identical strength of association or strength 
of evidence (Gliner et al., 2002; Wagenmakers, 2007).
When interpreting the data from many well-de-
signed and well-conducted studies, using a P-value of 
0.05 or less to determine statistical significance results 
in a relatively low to moderate likelihood that one will 
conclude that a difference between treatments or risk 
factors is present when there is truly no difference. 
However, it is important to recognize that the P-value 
is not a direct estimate of the likelihood that the study 
findings are incorrect; rather, the risk of erroneous 
conclusions is related to both the P-value and the actu-
al (but unknown) relationship between the variables of 
interest and the study outcome. This fact should cause 
one to interpret a P-value from a confirmatory study 
based on a strongly supported hypothesis very differ-
ently than the same P-value from a discovery study 
based on little or no prior supporting evidence.
Interpreting scientific literature to make clinical and 
management decisions is somewhat analogous to a clin-
ical interpretation of a diagnostic test. Diagnostic test 
accuracy is often expressed in terms of sensitivity (the 
ability to correctly identify positive animals) and speci-
ficity (the ability to correctly identify negative animals). 
Although these variables are important, the likelihood 
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of false-positive and false-negative testing classification 
errors is strongly influenced by the true prevalence of 
the disease in the population. As an example, consider 
testing a population of cattle for bovine viral diarrhea vi-
rus (BVdv; Fig. 2). Diagnostic tests with sensitivity and 
specificity of 98 and 99%, respectively, are available 
(Nickell et al., 2011). The expected prevalence for cattle 
persistently infected with BVDv in the general popula-
tion of feeder calves at the time of arrival at a feed yard 
is around 0.4% (Fulton et al., 2006). The calculated neg-
ative predictive value of using this test in this population 
is nearly 100% whereas the positive predictive value of 
using the test in this population is only 28% (Fig. 2A). 
In other words, a calf that we identify as test-positive is 
truly positive only 28% of the time. Despite high test 
specificity (99%), the positive predictive value (or the 
assurance that test-positive animals arriving at a feed 
yard are truly positive) is relatively low. Conversely, if 
we apply the same test in a herd that has been confirmed 
to have at least some cattle infected with BVDv and we 
expect the herd prevalence to be 10%, our positive pre-
dictive value becomes 92% (Fig. 2B). The sensitivity 
and specificity of the diagnostic test did not change, but 
our clinical interpretation is influenced by the underly-
ing true prevalence within the population.
In a similar manner, the true (but not precisely 
known) relationship between the variables of interest 
and the study outcome impacts how we should interpret 
our statistical results. Similar to limited certainty about 
true disease prevalence in a given situation, we lack a 
precise estimate of how many of our studies are testing 
factors with a true difference in outcomes. However, 
we can place studies into broad categories such as dis-
covery studies, where we expect that a low percentage 
of time there is truly a difference between observation 
groups or treatments (i.e., the null hypothesis is often 
true), and confirmatory work, where, based on previ-
ous studies, we expect a greater likelihood of finding 
a true biologic difference between observation groups 
or treatments. Providing an estimate of the percentage 
of studies that would truly result in differences if all 
knowledge was known allows us to generate calcula-
tions similar to the positive and negative predictive val-
ues. Although we might expect a relatively low risk of 
incorrect study interpretations (or times when we con-
clude there is truly a difference between treatment or 
Figure 2. Diagnostic test illustration of the influence of the commonness of a characteristic (being persistently infected [PI] with bovine viral diarrhea 
virus [BVDv]) on the interpretation of test outcomes when the test characteristics (diagnostic sensitivity and specificity) remain constant. The interpreta-
tion of a positive test result (positive predictive value) is very different when the prevalence of the tested condition is low (A) compared with when the 
prevalence of the tested condition is high (B), even though the test characteristics do not change.
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observation groups yet one does not exist) using a sig-
nificance level of 0.05, it is important to recognize that 
most discovery studies are investigating observation 
group or treatment populations that are truly not dif-
ferent. Therefore, if novel treatments or risk factors in-
vestigated in discovery studies are truly different from 
controls only 10% of the time, we would expect, when 
using a significance level of 0.05, to classify differenc-
es as “statistically significant” that approximately 38% 
of those conclusions could be in error (Fig. 3A).
Occasionally in discovery studies, the significance 
level is raised as high as a P-value of 0.10 to allow 
greater exploration of possible associations; however, 
if a P-value of 0.10 is applied to the example in Fig. 
3A, the risk of error in studies identified with a sta-
tistically significant difference between treatment or 
observation groups could be as high as 53%. Or, in 
other words, of all discovery studies that identified a 
statistically significant difference at P < 0.10, approxi-
mately half of those conclusions would be in error as 
no true difference exists. Therefore, a supposedly strin-
gent significance level of 0.05 may not be strict enough 
in true discovery work (Sterne and Smith, 2001). This 
limitation to simplistic interpretations of a specific 
P-value being classified as “statistically significant” 
and, therefore, being considered to support rejection of 
the null hypothesis of no effect may help explain recent 
findings that illustrated that many (47/53; 89%) recent 
landmark publications in global cancer research could 
not be replicated in subsequent work (Cull et al., 2012).
Not all studies are conducted in pure discovery 
mode with the associated high risk of investigating 
risk factors or treatments not different from controls. 
In confirmatory research studies, if hypotheses that 
risk factors or treatments result in outcomes different 
from controls were correct 40% of the time, the risk 
of concluding that a difference exists when none truly 
does using a significance level of P ≤ 0.05 is much 
lower than the same level applied to discovery stud-
ies (8%; Fig. 3B). If the hypotheses that treatment or 
observation groups are different were correct most of 
the time (>60%) in an area of study, the likelihood 
of incorrectly concluding a difference exists using 
a significance level of P ≤ 0.05 is low (<4%); how-
ever, research on topics already well characterized is 
rarely valuable for advancing scientific knowledge. 
Therefore, our assumption is that most research is 
performed on hypotheses where the true association 
is unknown and the likelihood of true differences be-
tween treatments or observation groups is relatively 
low; if P-values are incorrectly interpreted as an es-
timate of the risk of Type I error (i.e., based on the 
statistical analysis, concluding a difference between 
treatment or observation groups exists when there is 
truly no difference), the role of chance differences will 
be underestimated. Because one does not know the ac-
tual frequency that study variables result in true out-
come differences, using a conservative significance 
level (P ≤ 0.05, P ≤ 0.01, or P ≤ 0.001) provides a 
more rigorous statistical test and improves robustness 
of findings compared with accepting P-values > 0.05 
as being statistically significant. Knowledge of the bi-
ology and expected outcomes in an area of scientific 
investigation is needed to appropriately evaluate and 
interpret results (Sterne and Smith, 2001).
IntErPrEtInG P-VAluES  
ABoVE tHE SIGnIFIcAncE lEVEl  
(E.G., P > 0.05 or P > 0.01, Etc.)
An inference test that returns a P-value greater than 
the selected significance level indicates there is not 
enough evidence to attribute the observed difference 
to the treatment or observation groups in the study; 
chance may have produced an as-great or greater ob-
served difference (Greenland et al., 2016). Regardless 
of the magnitude of the P-value or the numerical dif-
ference between treatment or observation groups eval-
uated, a P-value above the selected significance level 
(e.g., P > 0.05) does not mean that the treatment or 
observation groups are equivalent (Greenland et al., 
2016). Inferences concerning an outcome difference 
between treatment or observation groups with a calcu-
lated P-value of 0.15 should not be different from com-
parisons with a P-value of 0.95 based on the P-values 
alone because both values lead to the conclusion there 
is little evidence of a difference among the study 
groups. For almost all studies, the hypothesis centers 
around testing whether differences between treat-
ment observation groups can be inferred to be due to 
the treatment rather than chance. If the statistical tests 
used in the study fail to remove chance as a reasonable 
explanation for observed differences (e.g., P-value > 
0.05 or P-value > 0.01 depending on the a priori des-
ignated significance level), we do not know whether 
the study did not have sufficient replicates to identify a 
true difference or whether there is truly no effect of the 
treatment or observation group. A P-value above the 
significance level does not distinguish between these 
2 explanations and no further conclusions should be 
drawn from the data. Post hoc power analysis methods 
can be used to determine the ability to detect a certain 
magnitude of difference between treatment or obser-
vation groups based on observed outcomes; however, 
the use of post hoc power analysis may be misleading 
and is generally discouraged (Smith and Bates, 1992; 
Goodman and Berlin, 1994).
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Figure 3. Depiction of studies (n = 100) to evaluate the expected results of discovery (A; 10% of trials have treatment or observation groups that are truly 
different) or confirmatory studies (B; 40% of trials have treatment or observation groups that are truly different) where trials identifying treatment or observa-
tion group differences are denoted with an “X” and the true state of the natural world is denoted by no difference between observation groups or treatments
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Interpreting P-Values in Light of Sample Size
Statistical results should be interpreted in light of 
the overall study design and the sample size. Increasing 
the number of replicates in each treatment or observa-
tion group improves the accuracy of the estimate of the 
study outcomes, but the amount of replication within 
each study group is a compromise between improving 
accuracy of the estimate of the effect and the constrain-
ing cost and effort (Voisinet et al., 1997a). The power 
of a study to find a difference can be influenced by the 
study design, the type of outcome variable being mea-
sured (quantitative vs. qualitative), and the number of 
replicates (sample size; Voisinet et al., 1997b). Small 
sample sizes may overestimate population variability 
and thus make it challenging to identify true differences 
of small magnitude; therefore, when small studies show 
no statistically significant differences, the findings 
should not be overinterpreted because in reality, little 
additional information has been gained from the study.
Conversely, when a small study shows a significant 
finding, the magnitude of effect between treatment or 
observation groups is either truly large or, by chance, is 
uncharacteristically large in the specific study population. 
In other words, if 2 treatments or risk factors are truly 
different but the true magnitude of difference is small, an 
underpowered study will find a statistically significant 
difference only when the numerical estimates for each 
treatment or observation group were obtained from the 
opposite tails of the population distributions. The magni-
tude of effect exhibited in studies with small sample size 
that report statistically significant differences is likely 
greater than the true magnitude exhibited between treat-
ment or observation groups in the larger population. In 
addition, a statistically significant difference identified 
with a small sample size may also challenge the appro-
priateness of extrapolating study results to other popula-
tions. The same number of animals (or other experimental 
units) used in the study may markedly differ from other 
samples that could be taken from the larger population, 
which may inhibit the ability to extrapolate results to a 
larger population (McGrath, 1987). If a study performed 
with 6 animals finds a significant difference among treat-
ments, the findings are likely real but at the high end of 
the range of possible results obtained by sampling the 
population. In addition, it may be unlikely these 6 ani-
mals accurately represent all of the variability present in 
the whole population; therefore, the study may need to 
be repeated to improve the precision of the estimate and 
the external validity of the findings.
Interpreting Confidence Intervals
In addition to or in place of calculating P-values 
for a hypothesis test, CI can also be calculated to ex-
press the degree of uncertainty associated with the 
study outcome. Whereas a P-value only provides in-
formation about how incompatible the study data are 
with the null hypothesis (given that the study design and 
statistical methods are appropriate), a CI provides that 
information as well as information about the expected 
magnitude of the effect. Commonly reported CI are 90, 
95, and 99%. For a 90% CI, if sampling from a pop-
ulation was repeated 100 times, the CI calculated for 
each sample population would contain the true popula-
tion parameter of interest (e.g., mean, median, relative 
risk, odds ratio, proportion, etc.) 90 times and the true 
population parameter would fall outside the CI for each 
sample population 10 times. The CI provides a range of 
estimates that the study suggests contains the true popu-
lation parameter; however, the CI does not indicate the 
probability of the true population parameter within the 
interval identified from the study data (Trafimow and 
Marks, 2015; Greenland et al., 2016).
Selection of the CI to report is related to the desired 
precision and confidence of the estimate, in that greater 
confidence can be achieved with wider, less precise CI 
whereas, in contrast, narrower CI provide a more pre-
cise estimate with less confidence that the population 
parameter lies within the CI. The 95% CI will have a 
greater width than the 90% CI, and the difference in 
width of the 2 intervals is due to the probability that 
the true population value will lie within the CI calcu-
lated from multiple samplings of the same population. 
Using a 90% CI increases the hazard of concluding that 
a numerical difference identified from a study sample 
reflects a true difference in the population parameter 
when, in fact, no difference is present (increased risk of 
Type I error) compared with using a 95% CI. A 99% CI 
results in the least risk of making a Type I error but the 
greatest risk of failing to reject the null hypothesis of 
no difference between treatment or observation groups 
based on the statistical analysis when a difference truly 
exists (increased risk of Type II error).
Within a selected CI (e.g., 95%), a wide CI com-
municates that there is a great deal of uncertainty asso-
ciated with the sample-estimated outcome of interest. 
When used to infer whether or not a statistically signif-
icant difference is present, if the CI for the difference 
between treatment or observation groups excludes 
zero, the study data are considered to be incompat-
ible with the null hypothesis. Another way CI provide 
more information than P-values is when a comparison 
fails to reach the significance threshold; a CI provides 
a plausible magnitude of treatment effect, whereas 
a P-value that is larger than the chosen significance 
level (e.g., P > 0.05) does not provide any information 
beyond the study failing to reject the null hypothesis.
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table 1. Glossary of commonly used statistical and research design terms
Term Practical definition Why it is important to researchers
Bias Any factor that could systematically influence the study outcome 
away from the truth.
If study results are biased, inferences should not be made from 
the study.
Blinding Ensuring that no one involved in describing or measuring study 
variables, care of the animals, or analysis of the data has knowl-
edge of treatment exposure.
Blinding is one of the most effective mechanisms to prevent bias 
in outcome assessment and is essential when subjective variables 
are the primary outcomes.
Confidence interval 
(CI)
An estimation of the proportion of sample population intervals 
that would contain the true population a specified percent of the 
time. For a 95% CI, if a population was sampled 100 times, the 
95% CI from each sample population would encompass the true 
population parameter 95% of the time. The larger the sample size, 
the more precision there is in the outcome estimated resulting in 
a smaller CI.
Similar to the P-value, a CI provides information about the un-
certainty surrounding an estimate of the numerical difference in 
an outcome of interest between sampled treatment or observation 
groups as a reflection of the true difference between populations. 
In contrast to a P-value, a CI also provides information about the 
probable magnitude of effect, which is helpful when considering 
the clinical relevance of the results.
Confounding A specific type of bias when a factor other than the treatment or 
observation factor of interest is associated with the study outcome 
but this factor is not evenly distributed between treatment or ob-
servation groups.
When confounding is present (or possible) and not controlled, 
distinguishing treatment effects from the effect of the potential 
confounder is impossible, leading to an inability to draw firm 
conclusions from the research.
Experimental or obser-
vational unit
The smallest independent physical unit that is assigned to a treat-
ment (experimental study) or observed (observational study), and 
each experimental or observational unit must be able to receive a 
different treatment.
The experimental or observational unit for each hypothesis must 
be correctly identified by the investigator to ensure that the study 
has adequate sample size (e.g., power) and that the statistics tests 
were properly performed. Livestock studies often have hierarchi-
cal data with animals nested within pens nested within buildings 
nested within farms or with repeated measurements of the same 
units being taken over time. These types of hierarchical data 
structures makes selection of the correct experimental or observa-
tion unit and the appropriate statistical test more challenging and 
may result in different experimental or observational units being 
appropriate for different hypothesis in the same study.
External validity The ability for study results to accurately be generalized to other 
populations.
Research may be internally valid yet performed in a population 
much different from the population of clinical interest; therefore, 
extrapolating study results may not be possible.
Internal validity The study design is appropriate for the hypotheses and study vari-
ables while controlling for potential issues related to bias.
If the study is not internally valid, conclusions based on results 
should not be made.
Interaction The effect of one variable on the outcome of interest is modified 
by the effect of another variable.
Interactions are relatively common in biologic studies, and if 
present, they can influence interpretation of study outcomes.
Least squares mean The result of a statistical analysis to approximate the solution in 
a model fitting the outcome and adjusting for other variables in 
the model.
Least squares means are calculated from a model that adjusts the 
estimated mean based on variables included in the model. This 
adjustment should result in a more accurate estimate of the popu-
lation mean than a simple arithmetic mean of the sample data.
Multivariable analysis A statistical analysis that incorporates the relationship of more 
than 1 variable when evaluating the outcome of interest.
Biologic systems are complex, and often, experimental or ob-
servational units are not completely independent. Multivariable 
analyses allow for evaluation of effects while adjusting for poten-
tial variables that may be confounding, resulting in more accurate 
estimate of effects.
Null hypothesis The starting assumption for most research; the assumption that 
there is no difference among treatment or observation groups.
Because the initial assumption is no difference between treatment 
or observation groups, if the statistical tests fail to identify a dif-
ference, no real conclusions should be drawn from the findings 
(one can say only that the treatments were not statistically dif-
ferent at the magnitude observed with this study sample size). 
Failure to disprove the null hypothesis does not indicate that treat-
ment or observation groups are the same, only that they did not 
statistically differ in this study.
Numerical differences The outcomes (e.g., mean, median, relative risk, odds ratio, pro-
portion, etc.) of 2 treatment or observation groups differ, but the 
difference could be due to chance, bias, or true treatment or ob-
servation group differences.
Study findings may be described as numerically different but the 
difference could be due solely to chance and biological variabil-
ity. If a statistical difference was not identified in the presence of 
numerical differences between treatment or observation groups, 
this means either the sample size was too small to detect a true 
population difference of small magnitude or no difference exists. 
Conclusions should not be based on numerical differences alone.
Continued
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Biological versus Statistical Significance
The reader of a scientific paper must determine 
how much difference between treatment or observa-
tion groups is meaningful enough to support appli-
cation of the findings to specific animal populations. 
The magnitude of the difference between treatment or 
observation groups that reach the a priori test of be-
ing statistically significantly different is influenced by 
sample size (number of replicates in each treatment or 
observation group) and the inherent variability within 
the outcome being measured. Typically, when a small 
study identifies a statistically significant difference, 
the difference is relatively large, whereas a very large 
study can detect small numerical differences between 
treatment or observation groups.
Statistical tests do not provide information about the 
importance of numerical differences between treatment 
or observation groups. The reader must determine if the 
amount of difference between treatment or observation 
groups is biologically meaningful and represents a logi-
cal finding. A project evaluating physiological changes 
before and after bacterial respiratory disease challenge 
in cattle reported several statistical differences in the he-
matologic profile (Hanzlicek et al., 2010). In the study, 
there were significantly fewer leukocytes before chal-
lenge (9.58 × 103 cells/μL) compared with the day after 
table 1.  (cont.)
Term Practical definition Why it is important to researchers
P-value The result of a statistical test that reports the probability of an out-
come difference as great as or greater than that described by the 
study data being incompatible with a specific model for the data 
(the model typically assumes that study populations are truly not 
different as well as making other assumptions).
The P-value is used to determine statistical significance but can 
be interpreted only if the study is internally valid and the inter-
preter has knowledge about the study design and the topic being 
investigated. A P-value does not test for bias, study design, or the 
appropriateness of applying study results to other populations dis-
similar to the population tested. In addition, it does not measure 
the probability that the hypothesis is true or the probability the 
data were produced by chance.
Pseudoreplication The error of treating multiple observations from the same experi-
mental or observational unit as replications of independent ex-
perimental or observational units.
Taking multiple samples from a single experimental or observa-
tional unit and treating them as independent samples can lead to 
the danger of concluding that a difference exists when that may 
not be true.
Randomization A common process of assigning experimental units to treatment 
groups used to prevent inadvertent bias based on selection cri-
teria.
Randomization is the primary mechanism to mitigate the danger 
of selection bias and confounding. Randomization attempts to 
prevent a factor outside the study criteria being present in unequal 
distributions among the treatment groups.
Sample size The number of experimental or observational units for each treat-
ment or observation factor group within the study.
Adequate sample size is based on the outcome of interest, the 
expected variability of the outcome, and the expected magnitude 
of effect of the treatment or observation factor on the outcome. 
Without adequate sample size, studies could be referred to as un-
derpowered and are unlikely to identify true differences.
Statistically significant The results of a statistical test to compare results. The specific 
definition of the threshold of “significance” may vary among re-
searchers, but significance (α) levels of P ≤ 0.05 and P ≤ 0.01 are 
commonly used.
Denoting statistical significance describes the probability of ob-
serving a difference as large as or larger than that identified in 
the study with the current sample size if there were truly no dif-
ferences between treatment or observation groups (see P-value). 
This designation does not differentiate between studies with and 
without true differences between study groups, nor does a statisti-
cally significant difference indicate a finding that is necessarily 
biologically meaningful, and findings should be interpreted ac-
cordingly. The α selected to be considered statistically significant 
should be influenced by the number of comparisons being made, 
the type of hypothesis (confirmatory vs. discovery) being tested, 
and expert knowledge of the study subject.
Type I error Based on the statistical analysis, concluding that a difference 
among treatment or observation groups exists when there is truly 
no difference.
Even when treatment or observation groups do not truly differ, 
individual studies will identify statistical differences among treat-
ment or observation groups. The frequency with which this error 
occurs compared with true parameter differences is based on the 
significance (α) level or the CI selected and the underlying prob-
ability that the treatment or observation groups are truly different 
(discovery vs. confirmatory research).
Type II error Based on the statistical analysis, failing to reject the null hypoth-
esis of no difference between treatment or observation groups 
when a difference truly exists.
Even when treatment or observation groups truly differ[, indi-
vidual studies can fail to identify statistical differences among 
study groups. The frequency with which this error occurs is 
based on the power of the study (influenced by sample size and 
the selected beta or CI).
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challenge (12.57 × 103 cells/μL; Hanzlicek et al., 2010). 
The findings were statistically significant, yet both find-
ings are located in the middle of the normal laboratory 
reference range for leukocytes (7.0 to 14.0 × 103 cells/
μL). These results represent a logical biological process 
(increased white blood cells following induced bacterial 
respiratory disease) and a statistical difference was iden-
tified; however, a difference of this magnitude is not bio-
logically meaningful if the clinical objective is to identify 
a measure that could be used to rapidly diagnose respira-
tory disease. Care should be taken to interpret not just 
if there is a difference between treatment or observation 
groups but whether or not the difference would influence 
a clinical or management decision (Gliner et al., 2002).
The interpretation of numerical differences between 
treatments is not always easy, nor is it intuitive. There 
are instances when the temptation is to modify ones 
interpretation to reflect inherent biases, allowing nu-
merical differences that do not reach a priori established 
significance levels or CI tests of statistical significance 
to unduly influence clinical or management decisions. 
Knowledge about previous research is needed to deter-
mine whether a specific study design was discovery or 
confirmatory. If previous research supports the null hy-
pothesis of no difference between study treatment or ob-
servation groups, then a numerical difference in a well-
powered study that does not reach the significance level 
may add evidence of no effect. However, if no previous 
research has been performed comparing the study treat-
ment or observation groups, then an initial study most 
likely serves a discovery role and additional research is 
needed to appropriately evaluate outcomes. Although 
inferential statistics can give a qualitative indication of 
whether or not the study observations are incompatible 
with the null hypothesis (below the significance level), if 
the null hypothesis of no treatment or observation group 
effect cannot be rejected, numerical differences alone 
should not be used to drive clinical and management de-
cisions without information about study design, biology, 
and previous research (Wasserstein and Lazar, 2016).
SuMMArY And concluSIonS
A basic understanding of statistical principles is 
useful when interpreting studies to enhance decision-
making. Statistics provide a framework to transfer in-
formation from relatively small, well-designed research 
studies into information that can be applied to broader 
populations to support clinical and management deci-
sions. Table 1 provides a glossary of common statistical 
terms encountered in animal research as well as these 
terms’ practical importance for readers. It is important 
to realize that statistical results should be interpreted in 
light of a specific clinical or management question as 
well as content-specific expertise and knowledge about 
biology and study design to best use inferential statis-
tics to support clinical and management decisions.
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